Outcomes of Zygomatic Fractures: Cross- Sectional Study

Launched by ERASMUS MEDICAL CENTER · Jun 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the long-term outcomes of treatments for zygomatic fractures, which are breaks in the cheekbone area of the face. These types of injuries can impact not only how a person looks but also how they function and feel emotionally. The researchers at Erasmus MC in Rotterdam want to understand how satisfied patients are with their treatment and how it affects their quality of life after their injuries. The study will include adults aged 18 and older who received treatment for zygomatic fractures between January 2008 and June 2023.

If you or a loved one has had a zygomatic fracture and were treated at Erasmus MC during this time, you may be eligible to participate in this study. Participants will be asked to share their experiences and satisfaction related to their treatment, contributing valuable information that could help improve future care for similar injuries. The study uses advanced imaging technology called Cone Beam Computed Tomography (CBCT), which provides detailed images of the facial bones with low radiation exposure. Overall, this research aims to enhance our understanding of how to best care for patients with facial fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who sustained a zygomatic fracture and were treated at Erasmus MC from January 2008 to June 2023.
• • 2. Patients aged 18 years and older at the time of the initial treatment.
• Exclusion Criteria:
• • 1. Patients with incomplete or missing electronic medical records that lack essential demographic, clinical, or treatment-related information.
• • 2. Subsequent facial trauma: Patients who experienced additional facial trauma after the initial zygomatic fracture, which could affect the outcomes and complicate the assessment of the initial treatment.
• • 3. Zygoma arch fracture: Patients who have a zygomatic arch fracture. This will nog influence the asymmetry or physical appearance.
• • 4. Psychiatric or cognitive disorders: Patients with psychiatric or cognitive disorders that impair their ability to provide informed consent or complete the necessary fol-low-up evaluations and questionnaires.